<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="959" height="523" viewBox="0 0 959 523"><rect width="959" height="523" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(41,26)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0.5,0.5h800v400h-800Z" stroke="#ddd"/><g><g class="mark-group role-axis" aria-hidden="true"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-grid" pointer-events="none"><line transform="translate(0,400)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,360)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,320)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,280)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,240)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,200)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,160)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,120)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,80)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,40)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="800" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis titled 'Medication' for a discrete scale with 12 values: acarbose, repaglinide, nateglinide, glipizide, rosiglitazone, ending with metformin"><g transform="translate(0.5,400.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(39,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(104,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(170,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(236,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(301,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(367,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(432,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(498,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(563,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(629,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(695,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(760,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(38.844262295081975,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">acarbose</text><text text-anchor="end" transform="translate(104.41803278688525,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">repaglinide</text><text text-anchor="end" transform="translate(169.9918032786885,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">nateglinide</text><text text-anchor="end" transform="translate(235.56557377049182,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">glipizide</text><text text-anchor="end" transform="translate(301.1393442622951,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">rosiglitazone</text><text text-anchor="end" transform="translate(366.71311475409834,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">pioglitazone</text><text text-anchor="end" transform="translate(432.28688524590166,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">glyburide-metformin</text><text text-anchor="end" transform="translate(497.8606557377049,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">glimepiride</text><text text-anchor="end" transform="translate(563.4344262295082,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">insulin</text><text text-anchor="end" transform="translate(629.0081967213115,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">glyburide</text><text text-anchor="end" transform="translate(694.5819672131147,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">chlorpropamide</text><text text-anchor="end" transform="translate(760.155737704918,7) rotate(-45) translate(0,8)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">metformin</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="800" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(400,89.55403372560059)" font-family="sans-serif" font-size="11px" font-weight="bold" fill="#000" opacity="1">Medication</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Readmission Rate' for a linear scale with values from 0.0 to 1.0"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,400)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,360)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,320)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,280)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,240)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,200)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,160)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,120)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,80)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,40)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,400) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.0</text><text text-anchor="end" transform="translate(-7,360) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.1</text><text text-anchor="end" transform="translate(-7,320) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.2</text><text text-anchor="end" transform="translate(-7,280) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.3</text><text text-anchor="end" transform="translate(-7,240) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.4</text><text text-anchor="end" transform="translate(-7,200) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.5</text><text text-anchor="end" transform="translate(-7,160) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.6</text><text text-anchor="end" transform="translate(-7,120.00000000000001) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.7</text><text text-anchor="end" transform="translate(-7,79.99999999999999) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.8</text><text text-anchor="end" transform="translate(-7,39.99999999999999) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0.9</text><text text-anchor="end" transform="translate(-7,0) rotate(-45) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">1.0</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,400)" x2="0" y2="-400" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-24.365284911978165,200) rotate(-90) translate(0,-2)" font-family="sans-serif" font-size="11px" font-weight="bold" fill="#000" opacity="1">Readmission Rate</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-rect role-mark marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="Medication: metformin; Readmission Rate: 0.432509505703; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 19,988" role="graphics-symbol" aria-roledescription="bar" d="M760.655737704918,226.99619771863118h26.229508196721312v173.00380228136882h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: metformin; Readmission Rate: 0.46781530485; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 81,778" role="graphics-symbol" aria-roledescription="bar" d="M734.4262295081967,212.87387806011395h26.229508196721312v187.12612193988605h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: repaglinide; Readmission Rate: 0.54905782976; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 1,539" role="graphics-symbol" aria-roledescription="bar" d="M104.91803278688525,180.37686809616633h26.229508196721312v219.62313190383367h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: repaglinide; Readmission Rate: 0.459526873996; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 100,227" role="graphics-symbol" aria-roledescription="bar" d="M78.68852459016394,216.1892504015884h26.229508196721312v183.8107495984116h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: nateglinide; Readmission Rate: 0.486486486486; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 703" role="graphics-symbol" aria-roledescription="bar" d="M170.4918032786885,205.4054054054054h26.229508196721312v194.5945945945946h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: nateglinide; Readmission Rate: 0.46070272998; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 101,063" role="graphics-symbol" aria-roledescription="bar" d="M144.2622950819672,215.7189080078763h26.229508196721312v184.2810919921237h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: chlorpropamide; Readmission Rate: 0.453488372093; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 86" role="graphics-symbol" aria-roledescription="bar" d="M695.0819672131147,218.60465116279073h26.229508196721312v181.39534883720927h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: chlorpropamide; Readmission Rate: 0.460887096774; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 101,680" role="graphics-symbol" aria-roledescription="bar" d="M668.8524590163934,215.64516129032256h26.229508196721312v184.35483870967744h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: glimepiride; Readmission Rate: 0.469466384126; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 5,191" role="graphics-symbol" aria-roledescription="bar" d="M498.3606557377049,212.21344634945095h26.229508196721312v187.78655365054905h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: glimepiride; Readmission Rate: 0.460419363189; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 96,575" role="graphics-symbol" aria-roledescription="bar" d="M472.1311475409836,215.83225472430755h26.229508196721312v184.16774527569245h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: glipizide; Readmission Rate: 0.487308844395; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 12,686" role="graphics-symbol" aria-roledescription="bar" d="M236.06557377049182,205.07646224184137h26.229508196721312v194.92353775815863h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: glipizide; Readmission Rate: 0.457117198024; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 89,080" role="graphics-symbol" aria-roledescription="bar" d="M209.8360655737705,217.15312079030085h26.229508196721312v182.84687920969915h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: glyburide; Readmission Rate: 0.455399061033; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 10,650" role="graphics-symbol" aria-roledescription="bar" d="M629.5081967213115,217.84037558685446h26.229508196721312v182.15962441314554h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: glyburide; Readmission Rate: 0.461521576891; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 91,116" role="graphics-symbol" aria-roledescription="bar" d="M603.2786885245902,215.39136924360153h26.229508196721312v184.60863075639847h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: pioglitazone; Readmission Rate: 0.481850436681; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 7,328" role="graphics-symbol" aria-roledescription="bar" d="M367.21311475409834,207.25982532751095h26.229508196721312v192.74017467248905h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: pioglitazone; Readmission Rate: 0.459253690252; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 94,438" role="graphics-symbol" aria-roledescription="bar" d="M340.983606557377,216.29852389927782h26.229508196721312v183.70147610072218h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: rosiglitazone; Readmission Rate: 0.482953652789; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 6,365" role="graphics-symbol" aria-roledescription="bar" d="M301.6393442622951,206.81853888452474h26.229508196721312v193.18146111547526h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: rosiglitazone; Readmission Rate: 0.459408182304; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 95,401" role="graphics-symbol" aria-roledescription="bar" d="M275.40983606557376,216.23672707833254h26.229508196721312v183.76327292166746h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: acarbose; Readmission Rate: 0.594155844156; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 308" role="graphics-symbol" aria-roledescription="bar" d="M39.344262295081975,162.33766233766235h26.229508196721312v237.66233766233765h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: acarbose; Readmission Rate: 0.460476256185; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 101,458" role="graphics-symbol" aria-roledescription="bar" d="M13.114754098360663,215.8094975260699h26.229508196721312v184.1905024739301h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: insulin; Readmission Rate: 0.481713035324; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 54,383" role="graphics-symbol" aria-roledescription="bar" d="M563.9344262295082,207.31478587058456h26.229508196721312v192.68521412941544h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: insulin; Readmission Rate: 0.436971065572; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 47,383" role="graphics-symbol" aria-roledescription="bar" d="M537.7049180327868,225.21157377118374h26.229508196721312v174.78842622881626h-26.229508196721312Z" fill="#6d6d6d"/><path aria-label="Medication: glyburide-metformin; Readmission Rate: 0.475920679887; status: Prescribed; Medication Status: Prescribed; Status: Prescribed; Number of Patients: 706" role="graphics-symbol" aria-roledescription="bar" d="M432.78688524590166,209.6317280453258h26.229508196721312v190.3682719546742h-26.229508196721312Z" fill="#2b64e0"/><path aria-label="Medication: glyburide-metformin; Readmission Rate: 0.460775776766; status: Not Prescribed; Medication Status: Not Prescribed; Status: Not Prescribed; Number of Patients: 101,060" role="graphics-symbol" aria-roledescription="bar" d="M406.55737704918033,215.689689293489h26.229508196721312v184.310310706511h-26.229508196721312Z" fill="#6d6d6d"/></g><g class="mark-group role-legend" role="graphics-symbol" aria-roledescription="legend" aria-label="Symbol legend titled 'Medication Status' for fill color with 2 values: Not Prescribed, Prescribed"><g transform="translate(818,0)"><path class="background" aria-hidden="true" d="M0,0h95v40h-95Z" pointer-events="none"/><g><g class="mark-group role-legend-entry"><g transform="translate(0,16)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-group role-scope" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h82.1376953125v11h-82.1376953125Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#6d6d6d" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">Not Prescribed</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,13)"><path class="background" aria-hidden="true" d="M0,0h82.1376953125v11h-82.1376953125Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#2b64e0" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">Prescribed</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-text role-legend-title" pointer-events="none"><text text-anchor="start" transform="translate(0,9)" font-family="sans-serif" font-size="11px" font-weight="bold" fill="#000" opacity="1">Medication Status</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-title"><g transform="translate(400,-20.535533905932738)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-text role-title-text" role="graphics-symbol" aria-roledescription="title" aria-label="Title text 'Readmission Rates: Not Prescribed vs Prescribed'" pointer-events="none"><text text-anchor="middle" transform="translate(0,10)" font-family="sans-serif" font-size="13px" font-weight="bold" fill="#000" opacity="1">Readmission Rates: Not Prescribed vs Prescribed</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>